This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


29May 2020

Back to Seminars overview

International seminar by Richard Sherwood

Richard Sherwood
Brigham and Women's Hospital and Harvard Medical School, Boston, United States

Predictable and precise functional genomic CRISPR-Cas9 screening

Friday, May 29, 2020, 11.00 hours
Piet Borst Auditorium, Netherlands Cancer Institute        

Host: Arnout Schepers

Rich Sherwood received a B.S. in biological sciences at Stanford University, and as a member of Irving Weissman's lab developed the first method for prospective isolation of adult muscle stem cells. He got his PhD with Doug Melton at Harvard University in 2009, using emerging genomic methods to help develop a roadmap for the differentiation of embryonic stem cells into pancreatic cell types. He then performed an independent fellowship at Brigham and Women's Hospital and Harvard Medical School, developing a research program that combines genomics, genome editing, stem cell biology, and machine learning to understand how genome sequence encodes gene regulatory activity and to predict how changes in patients' genome sequences cause disease. He is now an assistant professor at Brigham and Women's Hospital and Harvard Medical School and has published several recent papers that improve our ability to harness CRISPR/Cas9 to understand and treat genetic disease.

Share this page